Additionally, emerging evidence suggests that both SP1 and STAT3 can suppress the expression of pivotal genes implicated in adipocyte differentiation, including PPARγ, C/EBPα, and FABP4, thereby potentially restoring insulin sensitivity and mitigating obesity [43,44]. This evidence concerns the gene CEBPA and obesity disorder.